NovAccess Global, Inc., formerly XsunX, Inc., is a biomedical company. The Company focuses to provide diagnostics and therapeutics for cancer and neurological diseases. The Company utilizes immunotherapy approaches to enhance the patient’s own immune cells to recognize and kill cancer cells. It is engaged in developing technology that utilizes artificial intelligence platforms to provide personalized and patient-centered care. Its technology, StemVax Therapeutics, has an...